SenzaGen

The Outcome

SenzaGen AB was granted € 2.4M from the SME Instrument, HORIZON 2020, phase 2. 

The Company

SenzaGen AB is a privately-owned Biotech-company, providing methods for assessment of immunotoxicological properties of chemical compounds and mixtures. Continuous R&D activities aims to broaden the application domain of provided services, and the company have close connections to immunological and toxicological researchers at Lund University, Sweden.

The project

The GARDair project will optimize and validate the first predictive assay for respiratory sensitization and bring it to market. This innovative in vitro test builds on the successes of its forerunner – the GARDskin assay, which has been shown to hold the highest predictive power (89%) of skin sensitizers amongst all commercially available methods. The GARD technology offers an unparalleled way to make hazard predictions, as it uses a human dendritic cell line to monitor immunological responses to chemical exposure. If successful, the project will allow SenzaGen to become a key player in any application of animal-free, cell-based systems, aiming to assess sensitization capabilities of various compounds and to fully realize its business development strategy.

GAEU's role

GAEU has been deeply involved in structuring the scope and configuration of the project and its budget. GAEU conducted workshops with the client and wrote the successful SME Instrument phase 2 application. GAEU also produced the Grant Agreement.

Testimonial

“At SenzaGen, we have strong ambitions to grow and enable animal-free, cell-based systems to assess hazards and potency of industrial compounds. The grant we have received will be the perfect catalyst for this vision. We will use the funding to bring an innovative product to the market, with potential to become the cornerstone of our long-term competitiveness. For a small life science company, a grant covering 100 % of the project costs is of unparalleled value. We would like to thank GAEU for supporting us to secure this grant. We have received excellent guidance and advice in the application process. The team responsible for our proposal was easy to work with and very knowledgeable. GAEU is an excellent Horizon 2020 advisor and long term business partner.” Anki Malmborg Hager CEO

Anki Malmborg Hager, CEO

MORE CASE STUDIES

FOLLOW US